Public company
Krystal Biotech, Inc.
KRYSCIK 0001711279
Price$300.88
1 year+50.5%
Disclosed transactions10
Buys / sells0 / 2
Max Insider Score20
Connections with evidence6
KRYS · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Mason ChristopherDirector | KRYSKrystal Biotech, Inc. Grant or award | A | — 1,187 sh | Sep 16, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Holds over 5% ofevidenceVanguard Portfolio Management4.43% of class · Schedule 13G · Oct 29, 2026
- ← Insider ofevidenceMazzacco CatherineDirector · Sep 16, 2026
- ← Insider ofevidenceSutherland Everett RandDirector · Sep 16, 2026
- ← Insider ofevidence